Every year, the Cystic Fibrosis Trust is committed to spending at least £4.5 million, money which funds medical research, clinical support and family care. All clinical and research projects are scrutinised by an international panel of leading doctors and scientists. This ensures that every pound is distributed to areas of most need and potential scientific impact.

CF Trust-funded research leads the field in the search for a cure. The research also addresses the serious symptoms and complications of the disease, which include infection, inflammation, malnutrition, liver failure and osteoporosis. It is vital for CF patients to remain healthy as possible, both in the short term and to gain from the long-term benefits of a cure. The trust are currently committed to spending £3.4 million on research projects.

Since the identification of the gene that causes CF in 1989, research is increasingly focused on correcting that basic genetic defect. Two approaches are being explored: Gene therapy - replacing the faulty gene with a healthy copy - and protein repair - repairing or replacing the faulty protein, which is created by the defective gene.
 

Please click here for 3rd page